The implementation of a translational study involving a primary care based behavioral program to improve blood pressure control: The HTN-IMPROVE study protocol (01295) by Bosworth, Hayden B et al.
Implementation
Science
Bosworth et al. Implementation Science 2010, 5:54
http://www.implementationscience.com/content/5/1/54
Open Access STUDY PROTOCOL
© 2010 Bosworth et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Study protocol The implementation of a translational study 
involving a primary care based behavioral program 
to improve blood pressure control: The 
HTN-IMPROVE study protocol (01295)
Hayden B Bosworth*1,2,3, Daniel Almirall1,4, Bryan J Weiner5, Mathew Maciejewski1,2, Miriam A Kaufman1, 
Benjamin J Powers1,2, Eugene Z Oddone1,2, Shoou-Yih D Lee5, Teresa M Damush6, Valerie Smith1, Maren K Olsen1,4, 
Daren Anderson7, Christianne L Roumie8, Susan Rakley1, Pamela S Del Monte1, Michael E Bowen9, Jeffrey D Kravetz7 
and George L Jackson1,2
Abstract
Background: Despite the impact of hypertension and widely accepted target values for blood pressure (BP), 
interventions to improve BP control have had limited success.
Objectives: We describe the design of a 'translational' study that examines the implementation, impact, sustainability, 
and cost of an evidence-based nurse-delivered tailored behavioral self-management intervention to improve BP 
control as it moves from a research context to healthcare delivery. The study addresses four specific aims: assess the 
implementation of an evidence-based behavioral self-management intervention to improve BP levels; evaluate the 
clinical impact of the intervention as it is implemented; assess organizational factors associated with the sustainability 
of the intervention; and assess the cost of implementing and sustaining the intervention.
Methods: The project involves three geographically diverse VA intervention facilities and nine control sites. We first 
conduct an evaluation of barriers and facilitators for implementing the intervention at intervention sites. We examine 
the impact of the intervention by comparing 12-month pre/post changes in BP control between patients in 
intervention sites versus patients in the matched control sites. Next, we examine the sustainability of the intervention 
and organizational factors facilitating or hindering the sustained implementation. Finally, we examine the costs of 
intervention implementation. Key outcomes are acceptability and costs of the program, as well as changes in BP. 
Outcomes will be assessed using mixed methods (e.g., qualitative analyses--pattern matching; quantitative methods--
linear mixed models).
Discussion: The study results will provide information about the challenges and costs to implement and sustain the 
intervention, and what clinical impact can be expected.
Background
Controlling hypertension improves cardiovascular and
renal outcomes, and the mechanisms for achieving con-
trol including diet, exercise, and medications are well
known and accepted. Despite the increased incidence of
hypertension-related diseases, well-established evidence-
based guidelines, and the availability of over 100 antihy-
pertensive medications, approximately 25% to 40% of vet-
erans with hypertension in 2007 did not have adequate
blood pressure (BP) control (≥140/90 mmHg) [1].
To address this problem, the Department of Veterans
Affairs (VA) healthcare system recently set a target of
bringing 75% of hypertensive patients under effective BP
control. To achieve this target, the VA needs to deploy
evidence-based interventions that are effective, sustain-
able, and scalable for a large, complex healthcare delivery
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system. In prior research, our group has demonstrated
the efficacy and cost-effectiveness of a nurse-delivered
tailored behavioral self-management intervention in a
population of hypertensive United States veterans [2].
Several VA facility leaders have expressed interest in
using this intervention to reach the 75% target. Despite
scientific evidence that the intervention works, these
facility leaders and other potential adopters want to
know: What will it take to implement the intervention
successfully outside the context of a randomized con-
trolled trial? When implemented 'in the real world,' will it
produce the same results that it produced in the trial?
What is necessary to sustain intervention delivery over
time? Finally, what are the costs to implement and sustain
the intervention?
In this article, we describe the design of a 'translational'
study that implements an evidence-based nurse-delivered
tailored behavioral self-management intervention to
improve BP control as it moves from a research context
to a dynamic practice context. Specifically, the study
seeks to: identify organizational factors associated with
effective implementation of the intervention in VA facili-
ties; evaluate the clinical impact of the intervention when
implemented outside the context of a randomized con-
trolled trial; assess organizational factors associated with
the sustained delivery of the intervention over time; and
calculate cost of the intervention as it is implemented by
VA facilities. Guided by innovation and organization the-
ory, this mixed-methods study examines these issues in
three sites implementing the behavioral self-management
intervention and nine usual care sites. Study results will
provide information about the challenges and costs of
implementing and sustaining the intervention in primary
care settings within large, complex healthcare delivery
organizations and determine the clinical impact of the
intervention.
Methods
Conceptual framework
To guide this evaluation project, we use an organizational
model of innovation implementation (Figure 1) [3-6].
Briefly, the model posits that effective implementation of
an intervention (e.g., consistent, high-quality, appropriate
intervention delivery) is a function of organizational
readiness for change; quality of the implementation poli-
cies and practices that the clinic puts into place; adapta-
tions that the clinic makes to increase the fit of the
intervention with clinic operations; the climate for imple-
mentation that results from these policies, practices, and
adaptations; the extent to which intended users (e.g., phy-
sicians, nurses) perceive that the intervention reflects
their values (e.g., professional autonomy, practice bound-
aries); and the extent to which clinic-level and organiza-
tional changes reinforce or reduce the climate for
implementation (e.g., users' perceptions that intervention
use is rewarded, supported, and expected). Effectiveness
of the intervention (e.g., benefits, costs, and outcomes)
depends, in part, on effective implementation. Effective-
ness of the intervention, in turn, shapes users' percep-
tions that the intervention is worthwhile (rewarded,
supported, and expected), which then affects the sustain-
ability of the intervention.
Overview of the intervention and its efficacy
The intervention is a nurse-delivered tailored telephone
intervention that was developed and previously evaluated
in the Veteran-Study To Improve The Control of Hyper-
tension (V-STITCH) [7,8], and refined in Take Control of
Your Blood (TCYB) Pressure study [9-11] and Hyperten-
sion Intervention Nurse Telemedicine Study (HINTS)
[12]. In total, over the past eight years more than 1,800
hypertensive patients have been enrolled and followed for
18 to 24 months in a version of the behavioral-educa-
tional self-management intervention. The intervention is
tailored to each patient's needs [13].
The intervention uses a behavioral-educational
approach to enhance hypertensive patients' self-manage-
ment capability and is organized around telephone
encounters that occur approximately once every 4 to 5
weeks for 12 months. During the phone calls, trained
nurses use the intervention software to gather medical
and behavioral information. Patient responses to these
questions activate a set of behavioral and educational
modules within the intervention software that address
such issues as social support, knowledge, health behav-
iors including smoking, weight loss, diet, alcohol use,
stress, and participatory decision making [8,10,12].
Overview of the implementation scheme
Setting of study
We have included three intervention sites located in three
separate Veterans Integrated Service Networks (VISNs).
Intervention facilities were selected based on four crite-
ria. First, these facilities perceived that they could further
benefit from improving the level of BP control at their
facilities. Second, their patient demographics (rural ver-
sus urban, proportion of minorities) vary, which
increases the generalizability of evaluation results. Third,
the investigators have established collaboration with the
leaders of these VISNs. Finally, the intervention sites
agreed to leverage resources and funds to support a nurse
(or nurses) required to implement the intervention. Each
intervention site is matched to three control sites (nine in
total) based on the level of VA organizational complexity
and VISN affiliation.
Implementation parameters
Organizations often find it necessary and desirable to
adapt evidence-based interventions to facilitate imple-Bosworth et al. Implementation Science 2010, 5:54
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mentation, encourage ownership, and enhance accept-
ability among target populations [14]. The challenge for
intervention developers is to encourage implementing
sites to adapt the intervention to meet local needs and
circumstances, yet discourage adaptations that under-
mine the intervention's 'active ingredients'--that is, the
core elements of the intervention that embody its theory
and internal logic, and produce its main effects [15-17].
We sought to balance the competing demands of adap-
tation and fidelity by requiring intervention sites to use
certain intervention features and implementation pro-
cesses while allowing them the flexibility to tailor other
aspects of the intervention and the implementation pro-
cess to local conditions, and providing intervention sites
with centralized implementation support (Table 1). This
approach allows us to incorporate lessons learned about
successfully implementing interventions in organiza-
tional settings like the VA, to create enough comparabil-
ity across implementing sites to support statistical and
qualitative analysis, and to discover from the variability
across implementing sites what works and what does not.
Facility implementation teams
Intervention facilities are required to commit at least four
staff members in this partnership to ensure open commu-
nication among site participants and increase the likeli-
hood of effective implementation: nurse interventionist,
site principal investigator (physician), representative of
the nursing administration, and information technology
(IT) support staff. Each site has to agree to fund at least
one-half of a full-time equivalent (FTE) nurse position,
filled by one or more individuals. The nurse(s) will need
to implement the program for two years--one year of
enrollment and one year of follow-up. The facilities are
responsible for determining nursing resources available
to deliver the intervention, so these individuals may
include both primary care staff nurses and individuals
with experience as case managers.
The facility also is required to identify a specific site
principal investigator, who leads the implementation
effort at the facility and acts as a conduit between the
facility and the centralized implementation support team.
In the case of the present study, this person is typically a
physician. In addition, participation requires the support
of the director of nursing, who has the authority to dedi-
cate nursing time for the intervention. Lastly, the site has
to designate an information technology staff to be a con-
tact and troubleshooter for the roll-out and use of the
intervention software.
Patient enrollment
Each intervention facility has the goal of enrolling 500
patients during the 12-month implementation period.
Patients can be referred to the intervention in any of the
following three ways, depending on the preferences of the
primary care providers at each intervention site:
1. For VA patients with a diagnosis of hypertension and
last BP reading of >140/90 mmHg, primary care provid-
ers receive a reminder that the patient has poorly con-
trolled hypertension that includes an option to place an
order for the behavioral-educational intervention.
2. An item has been added to the providers' primary
care screen in the VA electronic medical record that will
allow a patient's provider to order the intervention even if
the hypertension reminder has not been triggered for the
patient.
3. If few intervention orders are received, the nurse is
able to access a pre-populated list of patients who meet
Figure 1 Determinants of effective innovation implementation in organizations.
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the same criteria as the hypertension care reminder.
Starting with the patient with the most recent outpatient
BP record, the nurse would contact the patient's primary
care provider regarding the intervention.
Feedback to providers
Facilities can use one of two approaches to scheduling
patients. In some cases, facilities have developed a spe-
cific nurse telephone hypertension self-management
clinic established for the purpose of delivering the inter-
vention. Like other healthcare appointments, the clerk
receives an order from a primary care provider to sched-
ule a specific time for the nurse to call the patient. The
other option allows facilities to develop an alert that goes
to the nurse indicating that a new patient is in the queue
to be called. Upon calling the patient, the ordering pro-
vider is notified.
The nurse must place a note in the VA electronic medi-
cal record, the Computerized Patient Record System
(CPRS), to describe any patient concerns. The nurse is
responsible for addressing serious patient needs during
the call following standard facility/clinic operating proce-
dures.
Operating the intervention software
The intervention software is a distributed application
built using the Microsoft .net framework. Users navigate
to a VA intranet web page to launch the software. Using
this system, nurses are able to access records from their
site only. Data are transmitted within the VA protected
computer environment (i.e., behind the VA firewall)
using a point-to-point connection between the user's
computer and a centralized server as the user goes
through each screen that corresponds to call script and
data collection.
Centralized support by intervention developers
Centralized support for the intervention is being pro-
vided to facilities by the research team. The support uti-
lizes a number of processes from quality improvement
collaboratives, such as those developed by the Institute
for Healthcare Improvement (IHI) [18], including prelim-
inary steps in which structured information is collected
from facilities with the goal of helping them to plan for
implementation. For example, facilities were sent work-
sheets asking them to identify team members, how the
half FTE nurse would be acquired, and commitment sig-
natures from the director of primary care and the direc-
tor of primary care nursing. Monthly calls involving all
team leaders have begun and will continue throughout
the implementation period so that facilities can learn
from one another's experience. Study staff has traveled to
each facility to present information to physicians, mid-
level providers, and other intervention staff as well as
meet with facility leadership. Finally, the study project
manager sends weekly reminders to facilities asking
about meetings and workload for the economic analysis
component of the study. This type of centralized support
mirrors other quality improvement efforts of the VA
[19,20].
Involvement of outside experts
Part of the implementation process consists of presenta-
tions of our intervention to an expert panel and our key
stakeholders for review and comments. This implemen-
tation process (and its study) is being conducted with
support of the VA Quality Enhancement Research Initia-
tive (QUERI)) [21-23] program for stroke prevention and
care. QUERI is the VA's program for bridging health ser-
vices research and VA operations to study the processes
for implementing innovations in the VA healthcare sys-
tem. We also seek input from our advisory committee
which consists of members representing leaders at both
the local and VISN level and other key stakeholders
Table 1: Required elements and permitted adaptations to 
intervention features and implementation processes
Required elements Permitted adaptations
Site implementation team 
must include designated 
'innovation champion' and IT 
specialist.
Innovation champion can be 
nurse, physician, or manager.
Site implementation team 
must involve physicians, 
nurses, and administrators.
Implementation team 
structure and process (e.g., 
member roles, meeting 
frequency, and activities) can 
vary.
Site must commit one-half 
FTE for intervention position 
(i.e., the 'nurse').
Nurse can be registered 
nurse or other adequately 
trained clinician (e.g., 
pharmacist).
Nurse position can be filled 
by one person or multiple 
people (totaling one-half 
FTE).
Site must enroll a minimum 
of 500 patients in the first 12 
months of the 
implementation study 
period.
Sites can enroll patients 
through referral by primary 
care physicians or through 
pre-populated list by nurse.
Sites must establish a clinical 
reminder system that 
includes an option to order 
the intervention for patients 
with out of control 
hypertension (>140/90 
mmHg).
The reminder may either be 
based on the VA electronic 
medical record system or a 
paper reminder from the 
clinic intake nurse for a given 
patient visit.
Sites need to notify provider 
if patient enrolled in 
program.
Methods for providing 
feedback to providers may 
vary by site.
Site must participate in 
centralized support activities.
Methods for communicating 
with central site may vary by 
site.Bosworth et al. Implementation Science 2010, 5:54
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including representatives from VA Central Office. In
addition, this committee will help to disseminate the
intervention, if it is shown effective, on a national level.
Overview of the evaluation study design
The remainder of this article describes four different
components of the evaluation project that address imple-
mentation, clinical impact, sustainability, and costs of the
behavioral-educational intervention. Table 2 summarizes
major components of each study component. Figure 2
summarizes the overall study timeline. Figure 3 Summa-
rizes the analytic study timeline for objective 2.
Study one objective: implementation study
Study one addresses the first specific aim: to assess orga-
nizational factors associated with the successful imple-
mentation of an evidence-based behavioral intervention
to control BP. For this study, successful implementation of
the intervention is defined by the degree to which
patients receive scheduled phone calls that include pre-
sentation of content outlined by the intervention soft-
ware. Informed by the conceptual model, study one
research questions include: how do VA site leaders foster
organizational readiness to implement the intervention;
what VA clinic policies and practices are needed to sup-
port intervention use; and do VA clinics with a stronger
implementation climate show more consistent, high-
quality, appropriate intervention use as indicated by
proxies such as patient retention, BP levels, and medica-
tion adherence? This component also seeks to describe
the use of implementation approaches. While there are a
number of methods available for implementing interven-
tions, there is no consensus on the most efficient meth-
ods and dose of support for effectively implementing
interventions [24].
Design
Study one employs a case study design involving the col-
lection and analysis of both qualitative and quantitative
data. Case study methods are well-suited for studying
implementation processes, which tend to be fluid, non-
linear, and context-sensitive [25,26]. In addition to per-
mitting in-depth analysis of individual cases, case study
methods offer analytic strategies for systematically com-
paring patterns observed across cases [27]. The three VA
clinics implementing the intervention serve as the units
of analysis (i.e., the cases). Quantitative data from the
nine VA clinics in the comparison group account for sec-
ular trends in hypertension management practices and
clinical outcomes.
Data collection strategy
Study one draws upon primary data collected from multi-
ple sources using multiple methods to analyze potential
facilitators and barriers to implementing the interven-
tion, including site visits, semi-structured interviews,
phone calls, e-mail exchanges, and standardized surveys.
Prior to the launch of the intervention, we conduct inter-
views with the clinic director, physicians, nurses, IT staff,
and office staff identified by the local site principal inves-
tigator who are involved in or affected by the implemen-
tation of the intervention (N = 42 to 60 total) (Table 3).
We use a semi-structured interview guide to gather data
on organizational readiness for change, implementation
policies and practices, implementation climate, user-val-
ues fit, management support, and situational factors that
might positively or negatively affect implementation suc-
cess. Interviews will be audio-taped and transcribed ver-
batim. Monthly phone calls and discussion board
exchanges with implementation group clinics will provide
real-time data on what clinics are doing or not doing,
what is working or not working, what clinics plan to do,
and what assistance clinics need to support implementa-
tion. These data will not be audio-taped, but notes of the
phone calls and discussion board exchanges will be sum-
marized. These data provide supplemental information
on management support, implementation policies and
procedures, implementation climate, innovation-values
fit, and other constructs.
In addition to the wealth of qualitative data we plan to
collect, we administer two surveys. The Assessment of
Chronic Illness Care (ACIC) is implemented at baseline
and 12 months at both the implementation clinics. The
ACIC is developed to allow healthcare teams to evaluate
the degree to which their organization has implemented
practices suggested by the Chronic Care Model [28,29].
The ACIC has been shown to be responsive to quality
improvement efforts [30,31]. We administer a web-based
version of the survey to all primary care physicians, mid-
level providers, and nurses, as well as selected adminis-
trators and IT specialists.
At the same time the ACIC is administered, the Organi-
z a t i o n  R e a d i n e s s  t o  C h a n g e  S u r v e y  i s  a d m i n i s t e r e d .
Twelve items assess perceived efficacy of the core imple-
mentation group to carry out critical implementation
tasks effectively (e.g., coordinating implementation activi-
ties), perceived commitment of the core implementation
group to implement the intervention, and perceived com-
mitment of the user group to support and use the inter-
vention.
Monitoring the intensity and dose of the behavioral 
intervention
Variation is expected in the procedures used by facilities
to achieve the ability to deliver the phone calls as indi-
cated by the intervention software. Thus, the following
activities are used to fully capture the process for imple-
menting the nurse-directed self-management support
program:Bosworth et al. Implementation Science 2010, 5:54
http://www.implementationscience.com/content/5/1/54
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Table 2: Summary of study components
Aim Research question Unit analysis Analysis methods Outcome
1. Identify the 
organizational factors 
associated with the 
effective implementation 
of the intervention in VA 
facilities.
How do VA site leaders 
foster organizational 
readiness to implement 
the intervention?
What VA clinic policies and 
practices are needed to 
support intervention use?
Do VA clinics with a 
stronger implementation 
climate show more 
consistent, high-quality, 
appropriate intervention?
Organization (e.g., 
physicians, administrators, 
IT, nurses)
Qualitative/quantitative 
methods
An organizational model 
of implementation 
suitable for complex 
innovations and adapted 
to the context of clinical 
practice. While there are a 
number of methods 
available for 
implementing successful 
interventions, there lacks 
adequate examination of 
the most efficient 
methods for 
implementing this 
knowledge. An additional 
product of this phase of 
the study will be an 
evaluation of approaches 
to implementation of the 
behavioral intervention
2. Evaluate the clinical 
impact of the intervention 
when implemented 
outside the context of a 
randomized controlled 
trial.
What is the impact, in 
terms of average systolic 
BP improvement, of 
having implemented the 
behavioral intervention 
versus not having 
implemented the 
intervention as a facility-
wide (i.e., clinical-level) 
program?
Within sites that have 
implemented the 
behavioral intervention, 
what is the impact, in 
terms of average systolic 
BP improvement, of 
having received the 
intervention versus not 
having received the 
intervention?
Change in BP among those 
who receive the 
intervention relative to a 
comparison group of usual 
care
Quantitative methods Demonstrate improved 
systolic BP in clinics using 
the intervention relative to 
clinics who did not receive 
the intervention
3. Assess the 
organizational factors 
associated with the 
sustained delivery of the 
intervention over time.
How do the perceived 
benefits and costs of the 
intervention affect the 
sustained use of the 
intervention by VA clinics?
What policies and 
practices are necessary to 
support sustained use by 
clinics?
How do organizational 
factors like staff turnover, 
competing priorities, and 
organizational changes 
affect sustained use by 
clinics?
VA clinics serve as the 
units of analysis. Focus on 
six VA clinics 
implementing the 
intervention. Data from 
the six VA clinics in the 
comparison group used to 
account for secular trends
Qualitative methods Assess what 
implementation policies 
and practices are 
necessary to support 
sustainability and how 
organizational factors 
affect sustainability.Bosworth et al. Implementation Science 2010, 5:54
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1. We track the frequency of use of the intervention as
well as number of written materials provided in the inter-
vention sites.
2. We track the local variations and adaptations of our
effective program at the intervention sites.
3. We track facility attendance on all study conference
calls completed using a computer database to record the
received dose of the patient intervention. This will pro-
vide us data on the consistency, quality, and appropriate-
ness of intervention use.
Analysis plan
Consistent with a case study research design, we use pat-
tern-matching logic to guide data analysis [32]. In pat-
4. Calculate the cost of the 
intervention as 
implemented by VA 
facilities.
Do costs decline as the 
intervention moves from 
start-up and 
implementation to a 
steady state? Is the 
intervention cost-neutral 
or cost-saving?
What is the value of 
implementing the 
intervention in VA clinics 
and the possible value of 
disseminating the 
intervention to other 
primary care settings.
Same sample used in 
study two to estimate 
costs
Quantitative methods Detailed cost and resource 
estimates needed to 
implement the 
intervention will be 
available for all VA 
facilities.
Table 2: Summary of study components (Continued)
Figure 2 Overall timeline.
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t e r n - m a t c h i n g ,  a n  o b s e r v e d  p a t t e r n  i s  c o m p a r e d  t o  a
predicted one (e.g., hypothesized relationships shown in
the conceptual model). If the patterns match, the pre-
dicted pattern is said to receive support. If the patterns do
not, the investigator reformulates the predicted pattern
by developing and investigating alternative predictions.
Qualitative analysis
Procedurally, qualitative data analysis involves three
phases: data coding, within-case analysis, and between-
case analysis. In the first phase, we use qualitative data
analysis software (ATLAS.ti 5.2) to code the study data.
The conceptual model provides a starting list of codes,
which we supplement with emergent codes as needed. In
the second phase, we conduct a within-case analysis of
each VA clinic implementing the intervention. Using
ATLAS.ti, we generate reports of all text segments for
each code. We assess the degree to which the construct
appears in the data (its 'strength'), the degree to which the
construct positively or negatively affects implementation
(its 'valence'), and the degree to which relationships
among constructs match the conceptual model.
Quantitative analysis
Consistent with the organization-level focus of the con-
ceptual model, we aggregate and analyze quantitative
data at the VA clinic level (three intervention sites and
nine control sites). We then analyze the quantitative data
in conjunction with the qualitative data using the pattern-
matching logic described above. For example, using the
ACIC data, we examine whether VA clinics with more
developed organizational infrastructures and climates
supporting chronic care delivery at baseline exhibit
greater management support, stronger implementation
climates, better innovation-values fit, and more effective
implementation. These data also help us gauge whether
implementing the BP control intervention stimulated or
Figure 3 Analytic study timeline for objective two.
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Table 3: Anticipated sample size and composition for 
qualitative portion of the implementation survey
Role of Individual N per VA site Sample 
Total
Healthcare System
Site Principal Investigator 1 3
Site Administrator 1 3
Site-Affiliated Physicians/healthcare 
providers
8 to 10 24 to 30
Site clinic staff members (e.g., 
secretaries, nurses, pharmacists)
3 to 5 9 to 15
Site Information Technology 1 to 3 3 to 9
Total 14 to 20 42 to 60Bosworth et al. Implementation Science 2010, 5:54
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facilitated more systemic changes in chronic care organi-
zation and delivery within the implementing clinic, or
whether secular trends within the VA represent a plausi-
ble rival explanation for the results that we see.
Products
Study one is expected to produce a theoretically
informed, empirically grounded organizational model of
implementation suitable for complex innovations and
adapted to the context of clinical practice. An additional
p r o d u c t  o f  t h i s  p h a s e  o f  t h e  s t u d y  i s  a n  ev a l u a t i o n  o f
approaches to implementation of the behavioral interven-
tion.
Study two objective: clinical impact
Purpose
Study two seeks to assess the clinical impact of the imple-
mented behavioral self-management intervention in
order to assess the effectiveness of the intervention out-
side the supportive context of a randomized controlled
trial. The population of interest is veterans with hyper-
tension who meet criteria for the behavioral intervention
and visit their primary care clinic at the VA for routine
care. The two primary research questions are:
1. What is the impact, in terms of average systolic BP
improvement, of having implemented the behavioral
intervention versus not having implemented the inter-
vention as a facility-wide (i.e., clinical-level) program?
2. Within sites that have implemented the behavioral
intervention, what is the impact, in terms of average sys-
tolic BP improvement, of having received the interven-
tion versus not having received the intervention (eligible
but not approached for enrollment or eligible for enroll-
ment but declined)?
Question one is an organizational (or policy) question
that addresses the impact of rolling out the intervention
facility-wide by comparing facilities implementing the
behavioral intervention (implementation facilities) versus
those that do not (control facilities). Question two
addresses the impact of the intervention from the per-
spective of the patient by comparing patients receiving
the intervention versus those that do not within facilities/
clinics that implemented the intervention. Figure 2 sum-
marized the time periods for which comparisons occur.
Study design and sample
The study design is a clustered quasi-experimental (i.e.,
observational, non-equivalent groups) design with
repeated measures [32]. Patients (the unit of analysis) are
clustered within their facilities (clinics) and repeated BP
measurements are gathered for each patient for over 12
months of participation in the intervention. The longitu-
dinal design is unbalanced, meaning that BP values are
not observed at distinct time points and not all patients
contribute the same number of BP measurements. Due to
logistics (i.e., hospital director approval, FTE require-
ments), for question one, clinics are not randomly
assigned to implement versus not implement the behav-
ioral intervention. Similarly, for question two, patients
within facilities implementing the behavioral interven-
tion are not randomly assigned to receive the interven-
tion versus not receive the intervention.
For question one, the study sample includes all veterans
with hypertension, who meet criteria for the behavioral
self-management intervention, who visit participating
clinics (both implementation and control clinics) at least
three times in prior two years, and who have a BP mea-
surement taken during the first visit. For question two,
the study sample used to address question one is
restricted to patients at implementation facilities.
Measures
For both questions, the primary outcome is systolic BP, a
continuous variable. Time is measured continuously in
weeks since the first time a patient visits a participating
facility during the implementation roll-out. For question
one, the primary predictor variable is the implementation
indicator variable (1 = implementation facility; 0 = con-
trol facility). For question two, the primary predictor
variable is the treatment received indicator variable (1 =
patient was contacted by nurse and received at least one
phone call under the behavioral intervention; 0 = patient
did not receive treatment).
Data
This study relies primarily on data from the Veterans
Health Information Systems and Technology Architec-
ture (VistA), the electronic medical record system used to
support both inpatient and outpatient care in the VA.
Specifically, BP measurements (the primary outcome
variable for both questions) and other covariates will be
obtained from the Health Data Repository (HDR) for
patients in our target population of interest. BP measure-
ments in the HDR are date-stamped, allowing us to
derive time (as defined above) for data analysis. The
treatment received indicator variable (for question two)
w i l l  b e  o b t a i n e d  f r o m  t h e  s o f t w a r e  u s e d  b y  t h e  s t u d y
nurse to administer the behavioral self-management
intervention.
Confounding Bias
Because facilities are not randomized to implement or
not implement the behavioral intervention (question
one), and patients within implementation facilities are
not randomized to receive or not receive the intervention
(question two), an important challenge is the potential
presence of confounding variables. A confounder variable
is related to the outcome and is unevenly distributed
between 'treatment' conditions (implementation forBosworth et al. Implementation Science 2010, 5:54
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question one, and receiving treatment for question two),
but is not in the causal pathway between the intervention
and the outcome [33]. For question one, confounder vari-
ables may include facility-specific variables, such as the
size of the facility, facility complexity, facility quality
index, number of providers at the facility, a clinic's readi-
ness to change, and other organizational factors mea-
sured prior to implementation roll-out. For question two,
confounder variables may include patient-specific vari-
ables such as age, race, and clinical factors measured
prior to receiving (or not receiving) the behavioral inter-
vention--these include pre-intervention medication
adherence, BP, hypertension concordant diagnoses (dia-
betes, kidney disease), or hypertension discordant diag-
noses (chronic pain, mental illness). In order to minimize
confounding bias for question two, possible confounder
variables will be adjusted for in the data analyses.
Data Analysis
For both questions, a linear mixed modeling (LMM) [34]
strategy with random intercepts and slopes is used to
estimate mean changes in BP over time, while taking into
account the variability in BP for patients clustered within
facilities [34]. With LMMs, patients are not required to
have their repeated BP measurements taken over fixed
time intervals throughout the study. All patients in the
target population with at least one BP measurement are
included in the data analysis. Therefore, the LMM is par-
ticularly suitable for this study given the unbalanced
structure of the repeated BP measurements. This model
is also known variously as a growth model or hierarchical
linear model [35] for studying individual change within
facilities; patients (level two units) with repeated BP mea-
surements (level one) are nested within facilities (level
three). Due to the relatively small number of implementa-
tion versus control facilities, the LMM will not accommo-
date the adjustment for all possible facility-level
confounders of the impact of the implementation pro-
gram on BP outcomes; therefore, confounding bias for
question one will be examined qualitatively by interpret-
ing the results of the LMM in light of how facilities differ
on putative facility-level confounders. Putative patient-
level confounders of the effect of treatment received on
BP outcomes are included in the LMM for question two.
For both questions, the primary outcome of interest is the
mean difference in BP outcomes at 12 months, estimated
using each of the LMMs.
Statistical power and sample size considerations
Statistical power considerations are based on question
o n e .  B a s e d  o n  p r e v i o u s  d a t a  [ 7 , 3 6 ] ,  w e  a n t i c i p a t e  t h a t
both implementation and control clinics have at least 500
hypertensive patients visit the clinic during the imple-
mentation roll-out period for which BP measurements
are available (6,000 patients total). Due to the longitudi-
nal nested study design (i.e., repeated systolic BP mea-
surements on patients nested within clinics), clustering
by clinic and within-person correlations must be taken
into account in both the data analysis and power calcula-
tions. Following Donner and Klar [37], we use an inter-
cluster correlation coefficient (ICC) and the correlation
between repeated BP measurements to adjust the vari-
ance of a two-sample difference in means test (for the pri-
mary contrast of interest) in order to account for
clustering and the longitudinal design, respectively. Most
primary care clinical studies with a cluster design experi-
ence an ICC of approximately 0.01 to 0.05 [38]. Assuming
an ICC equal to 0.01 and a correlation of 0.50 between
baseline and 12-month systolic BP (these two assump-
tions are based on unpublished data from a previous
study [2]), a two-tailed Type I error rate of 0.05, and given
the sample size projections above, we expect to have 80%
power to detect effect sizes that are at least as large as
0.22 (approximately a small effect size according to
Cohen [39] for the mean difference in BP at 12 months).
These calculations assume a balanced design (three
implementation and three control sites) to simplify power
calculations. Based on previous data suggesting a stan-
dard deviation of 18 mmHg in systolic BP [2,40], a mini-
m u m  d e t e c t a b l e  e f f e c t  s i z e  o f  0 . 2 2  t r a n s l a t e s  t o  a
difference of approximately 4.0 mmHg in systolic BP
between implementation sites and control clinics.
Products
We anticipate one major product of the study to demon-
strate improved systolic BP in clinics using the interven-
tion relative to clinics who did not receive the
intervention.
Study three objective: sustainability study
Study three assesses the sustainability of the behavioral-
educational self-management intervention to control BP.
Just as it is necessary to study the processes through
which patients must make a long-term commitment to
self-management of hypertension, we study the ability of
VA facilities to make long-term commitments to support
the intervention. In this study, sustainability is operation-
alized as the willingness and capacity of VA facilities to
maintain intervention use beyond the initial 12-month
period in which new patients are enrolled and existing
patients continue to receive the intervention. Specifically,
three research questions are examined: How do the bene-
fits and costs of the intervention as perceived by various
stakeholders affect the sustained use of the intervention
by VA clinics? What policies and practices are necessary
to support sustained use by clinics? And how do organi-
zational factors like staff turnover, competing priorities,Bosworth et al. Implementation Science 2010, 5:54
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and organizational changes affect sustained use by clin-
ics?
Design
Study three employs a case study design involving the col-
lection and analysis of both qualitative and quantitative
data. VA clinics serve as the units of analysis (i.e., the
cases). The focus is on the three VA clinics implementing
the intervention. Data from the nine VA clinics in the
comparison group are used to account for secular trends
in hypertension management practices and clinical out-
comes.
Data collection strategy
We obtain quantitative data from the intervention soft-
ware on the clinics' actual use of the intervention beyond
the initial 12-month enrollment period. As in study one,
we obtain from the software data concerning the consis-
tency, quality, and appropriateness of intervention use
with respect to the 500 patients enrolled in the study. In
addition, we examine whether clinics have enrolled new
patients in the intervention and, if so, whether invention
delivery is consistent, high-quality, appropriate in the
expanded patient cohort.
Analysis plan
Study three uses a pattern-matching logic in which the
observed pattern of results is compared to the predicted
pattern described in the conceptual model. Likewise,
quantitative data are aggregated to the VA clinic level and
analyzed in conjunction with qualitative data using pat-
tern-matching logic. Using the ACIC data, we examine
whether VA clinics with more developed organizational
infrastructures and climates supporting chronic care
delivery at baseline exhibit more sustained use of the BP
intervention.
Products
Results of study three allow us to assess what implemen-
tation policies and practices are necessary to support sus-
tainability, and how organizational factors like staff
turnover, competing clinic priorities, and larger organiza-
tional changes affect sustainability. Understanding the
sustainability of the intervention is essential for ensuring
the implementation of the program across the wider VA.
Study four objective: healthcare costs
Purpose
Study four involves evaluating two types of costs usually
assessed in randomized trials (costs associated with
implementing the intervention and costs of veterans
receiving the self-management intervention), and a third
type of costs not assessed in randomized trials that relate
to intervention dissemination to the clinics, which
involves initial time costs of study investigators and clinic
leadership in the buy-in and planning phases of the study
[41]. Together, these three types of costs will create a
complete picture of the costs that would be incurred if
the intervention were adopted system-wide. Questions
addressed with this aim include: Are per patient costs dif-
ferent between intervention sites and control sites? Do
costs decline as the intervention moves from start-up to a
steady state? Assessment of cost-analysis also provides
useful information regarding the value of implementing
the intervention in VA clinics and the possible value of
disseminating the intervention to other primary care set-
tings.
Study design and sample
The study sample for the cost analysis includes the
matched cohorts of 6,000 veterans with hypertension
who meet criteria for the behavioral self-management
intervention and have at least one visit to the participat-
ing clinics during the intervention roll-out period and
have a BP measurement taken during the first visit (total
N = 6,000).
Intervention-related costs
This includes three costs: study investigator time modify-
ing the intervention in preparation for the roll-out
period; study investigator and clinic staff time spent dur-
ing the buy-in phase developing trust and commitment to
the implementation study; and study investigator and
clinic staff time spent on implementing the intervention
(e.g., planning, intervention training, nurse time) [41]. We
are tracking the length of time for all meetings and other
various communications to capture costs during the
intervention modification and buy-in phases. To capture
the amount of time the nurse spends on the phone with
each patient, as well as the total amount of time spent
documenting interactions with the patients, we utilize
information on elapsed time that is captured automati-
cally in the intervention software used by the nurses.
Patient time spent on the telephone with the nurse also is
obtained from the automatic elapsed time counter built
into the software. To track nurse time spent communicat-
ing with providers and patients via email/fax/mail follow-
ing the telephone intervention delivery, we provide the
nurse with a spreadsheet to log these communications by
patient and date. Costs for intervention supplies (com-
puters, telephones) are based on their acquisition price
from the manufacturer, and office space is calculated and
allocated over their expected 'lifetime' of use.
Resource utilization and costs
Inpatient utilization data from the patient treatment file
(PTF) data and outpatient utilization data from the Out-
patient Care File (OPC) are to be merged with VA Deci-
sion Support System (DSS) data on VA expenditures for
all trial participants to compare VA resource utilization of
veterans randomized to treatment clinics and veterans
randomized to control clinics before and during interven-Bosworth et al. Implementation Science 2010, 5:54
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tion roll-out. The outcome of interest is annual health-
care costs over the 12-month period, and the patient is
the unit of analysis. A VA payor perspective is applied. All
costs are to be valued in 2010 US dollars, based on the
Current Price Index-Medical (CPI-M).
Products
We anticipate a major product of the study to outline the
full range of costs required to implement and sustain the
intervention in the six intervention clinics relative to clin-
ics who did not receive the intervention.
Other issues
Conducting implementation research can be challenging
and because of initial IRB challenges, we had to modify
the study from six intervention sites and six control sites
to the current three intervention sites compared to nine
usual care sites.
Discussion
The prevalence of hypertension has increased to 29.3% in
2003 to 2004 [42], resulting in 65 million Americans with
hypertension (and upwards of 8.5 million veterans) and a
greater burden of cardiovascular disease outcomes [42].
With increased prevalence of hypertension and subse-
quent secondary diseases, and poor control in treated
patients, it is more important than ever to improve con-
trol of this prevalent disease.
Despite solid evidence of efficacy, there has long been a
knowledge-practice gap in implementing hypertension
interventions [43]. In addition, there has been inadequate
attention regarding the sustainability of effective inter-
ventions. As such, studying the implementation of the
behavioral-educational self-management intervention
offers an opportunity to advance scientific knowledge
about the challenges of intervention implementation and
sustainability. Furthermore, an examination of organiza-
tional barriers and facilitators of evidence-based inter-
ventions may also help to improve the dissemination of
evidence-based behavioral interventions for other
chronic diseases.
The clinical strengths of our evaluation project include:
building upon previously successful interventions that
h a v e  r e s u l t e d  i n  i m p r o v e d  B P  c o n t r o l ;  a n  i n t e rv e n t i o n
that uses resources already available in primary care clin-
ics and that could be redeployed in new ways to achieve
higher quality of care for patients with hypertension; and
assessing the costs associated with implementation of the
intervention. Demonstrating the costs of the intervention
will help ensure the dissemination of the intervention.
This implementation study capitalizes on the national
healthcare system of the VA to systematically examine
the local adoption of an effective program aimed to man-
age veterans' hypertension while informing implementa-
tion science. The goals of the intervention are aligned
with the performance goals of the hospital administration
as demonstrated with the leveraging of facility resources.
Nonetheless, implementation of evidence based practices
requires changes across the system, and this study is
designed to facilitate and evaluate such changes.
The magnitude of the gap between discovery and deliv-
ery cannot be understated. Nor can we underestimate the
gap between what we know and what we need to know in
terms of promoting the use of evidence-based guidelines
in primary care settings. Given the magnitude of the 'sys-
tems change' that may be required to meet hypertension
guidelines, the project may also have a significant impact
on veteran's health by helping the VA to accelerate the
translation of scientific advances into large-scale
improvements in health and substantial reductions in
health disparities. Findings from the current endeavor
may transcend the VA into other healthcare settings.
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